Sweden Herald
Australia Approves Leqembi for Early
Photo: Martina Holmberg / TT
Business

Australia Approves Leqembi for Early Alzheimer's Treatment

Australia's medical authority has approved the substance lecanemab, which is sold under the name Leqembi, as a treatment for early Alzheimer's, writes the Swedish company Bioarctic in a press release.

Advertisement

The approval applies to the treatment of adult patients with mild dementia or mild cognitive impairment due to Alzheimer's disease.

The drug Leqembi has been developed through a collaboration between Swedish Bioarctic and Japanese Eisai. Eisai is responsible for the clinical development and global sales.

In this story
Australiens läkemedelsmyndighetemaBioarcticqemb
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All